These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 6361325
21. [A clinical bacteriological efficacy study on a fosfomycin otic solution]. Deguchi K, Yokota N, Tanaka S, Fukayama S, Nishimura Y, Yoshihara H, Oda S, Matsumoto Y, Ikegami R, Sato K. Jpn J Antibiot; 1986 Sep; 39(9):2344-54. PubMed ID: 3099028 [Abstract] [Full Text] [Related]
23. [Fundamental and clinical studies of cefroxadine in pediatric field (author's transl)]. Toyonaga Y, Kurosu Y, Hori M, Kohno S. Jpn J Antibiot; 1981 Dec; 34(12):1608-25. PubMed ID: 7334586 [Abstract] [Full Text] [Related]
27. The development of antibiotic resistant organisms with the use of ototopical medications. Weber PC, Roland PS, Hannley M, Friedman R, Manolidis S, Matz G, Owens F, Rybak L, Stewart MG. Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367 [Abstract] [Full Text] [Related]
30. [Comparative study of clinical effects of cephalexin and aminobenzyl penicillin on acute suppurative inflammation of the middle ear by double blind test]. Nanjyo S, Suga A. Jibiinkoka; 1970 Sep; 42(9):719-24. PubMed ID: 4917278 [No Abstract] [Full Text] [Related]
33. Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. Supiyaphun P, Kerekhanjanarong V, Koranasophonepun J, Sastarasadhit V. J Med Assoc Thai; 2000 Jan; 83(1):61-8. PubMed ID: 10710871 [Abstract] [Full Text] [Related]
34. Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis. Haverkos HW, Caparosa R, Yu VL, Kamerer D. Arch Otolaryngol; 1982 Jun; 108(6):329-33. PubMed ID: 6212042 [Abstract] [Full Text] [Related]
35. [Clinical evaluation of cefroxadine in the field of obstetrics and gynecology]. Uchida S, Hayashi H, Tominaga M, Kohno K, Matsunaga M, Kudo S, Kawamura R. Jpn J Antibiot; 1983 Sep; 36(9):2549-55. PubMed ID: 6655869 [Abstract] [Full Text] [Related]
36. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)]. Deguchi K, Fukayama S, Nishimura Y, Yokota N, Tanaka S, Oda S, Matsumoto Y, Ikegami R, Sato K, Fukumoto T. Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415 [Abstract] [Full Text] [Related]
37. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections]. Horii M, Morinaga T, Takeuchi T, Shimada S, Yamanaka H, Nishimura T, Noshi Y, Okada T, Sasaki T, Takada S. Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193 [Abstract] [Full Text] [Related]
38. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections. Mogabgab WJ. Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284 [No Abstract] [Full Text] [Related]